PNC Financial Services Group’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$40.1K Sell
4,270
-2,006
-32% -$18.8K ﹤0.01% 3234
2025
Q1
$44.6K Buy
6,276
+1,049
+20% +$7.46K ﹤0.01% 3165
2024
Q4
$60.9K Sell
5,227
-11,633
-69% -$136K ﹤0.01% 2981
2024
Q3
$346K Buy
16,860
+536
+3% +$11K ﹤0.01% 1794
2024
Q2
$365K Buy
16,324
+368
+2% +$8.24K ﹤0.01% 1711
2024
Q1
$439K Buy
15,956
+5,395
+51% +$148K ﹤0.01% 1615
2023
Q4
$322K Buy
10,561
+7,151
+210% +$218K ﹤0.01% 1807
2023
Q3
$108K Sell
3,410
-357
-9% -$11.3K ﹤0.01% 2527
2023
Q2
$154K Buy
3,767
+260
+7% +$10.6K ﹤0.01% 2385
2023
Q1
$131K Sell
3,507
-25
-0.7% -$932 ﹤0.01% 2399
2022
Q4
$123K Buy
3,532
+35
+1% +$1.22K ﹤0.01% 2434
2022
Q3
$198K Sell
3,497
-17
-0.5% -$963 ﹤0.01% 2091
2022
Q2
$181K Sell
3,514
-4,043
-54% -$208K ﹤0.01% 2215
2022
Q1
$549K Sell
7,557
-6,740
-47% -$490K ﹤0.01% 1588
2021
Q4
$1.69M Sell
14,297
-3,513
-20% -$416K ﹤0.01% 1035
2021
Q3
$2.39M Sell
17,810
-782
-4% -$105K ﹤0.01% 853
2021
Q2
$3.01M Buy
18,592
+36
+0.2% +$5.83K ﹤0.01% 790
2021
Q1
$1.49M Buy
18,556
+198
+1% +$15.9K ﹤0.01% 1007
2020
Q4
$998K Buy
18,358
+5,000
+37% +$272K ﹤0.01% 1126
2020
Q3
$266K Buy
13,358
+658
+5% +$13.1K ﹤0.01% 1764
2020
Q2
$266K Sell
12,700
-10,000
-44% -$209K ﹤0.01% 1772
2020
Q1
$278K Buy
22,700
+2,700
+14% +$33.1K ﹤0.01% 1627
2019
Q4
$294K Buy
20,000
+10,950
+121% +$161K ﹤0.01% 1823
2019
Q3
$120K Sell
9,050
-950
-10% -$12.6K ﹤0.01% 2437
2019
Q2
$164K Sell
10,000
-485
-5% -$7.95K ﹤0.01% 2278
2019
Q1
$179K Buy
10,485
+485
+5% +$8.28K ﹤0.01% 2206
2018
Q4
$136K Buy
+10,000
New +$136K ﹤0.01% 2289
2017
Q4
Sell
-100
Closed -$2K 4212
2017
Q3
$2K Hold
100
﹤0.01% 4016
2017
Q2
$2K Hold
100
﹤0.01% 3998
2017
Q1
$2K Hold
100
﹤0.01% 3954
2016
Q4
$2K Hold
100
﹤0.01% 3845
2016
Q3
$2K Hold
100
﹤0.01% 3822
2016
Q2
$2K Buy
+100
New +$2K ﹤0.01% 4198